NO954135L - Fiskebukspyttkjertel-sykdomsvirus - Google Patents
Fiskebukspyttkjertel-sykdomsvirusInfo
- Publication number
- NO954135L NO954135L NO954135A NO954135A NO954135L NO 954135 L NO954135 L NO 954135L NO 954135 A NO954135 A NO 954135A NO 954135 A NO954135 A NO 954135A NO 954135 L NO954135 L NO 954135L
- Authority
- NO
- Norway
- Prior art keywords
- virus
- pancreatic disease
- disease virus
- fish pancreatic
- fish
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 208000016222 Pancreatic disease Diseases 0.000 title abstract 2
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 241000277263 Salmo Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9420956A GB9420956D0 (en) | 1994-10-18 | 1994-10-18 | Virus |
GBGB9508704.5A GB9508704D0 (en) | 1995-04-28 | 1995-04-28 | Virus |
GBGB9509425.6A GB9509425D0 (en) | 1995-05-10 | 1995-05-10 | "Virus" |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954135D0 NO954135D0 (no) | 1995-10-17 |
NO954135L true NO954135L (no) | 1996-04-19 |
NO317547B1 NO317547B1 (no) | 2004-11-15 |
Family
ID=27267435
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19954135A NO317547B1 (no) | 1994-10-18 | 1995-10-17 | Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens. |
NO2011024C NO2011024I2 (no) | 1994-10-18 | 2011-10-28 | Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2011024C NO2011024I2 (no) | 1994-10-18 | 2011-10-28 | Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen |
Country Status (9)
Country | Link |
---|---|
US (2) | US5939073A (no) |
EP (1) | EP0712926B1 (no) |
JP (1) | JP3676449B2 (no) |
AT (1) | ATE251667T1 (no) |
CA (1) | CA2160764C (no) |
DE (1) | DE69531891D1 (no) |
DK (1) | DK0712926T3 (no) |
NO (2) | NO317547B1 (no) |
PT (1) | PT712926E (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0626635B1 (en) * | 1993-05-24 | 2003-03-05 | Sun Microsystems, Inc. | Improved graphical user interface with method for interfacing to remote devices |
ATE369429T1 (de) * | 1998-05-08 | 2007-08-15 | Intervet Int Bv | Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen |
CA2393895A1 (en) * | 2001-07-17 | 2003-01-17 | University Of Prince Edward Island | Serological test for isav in fish |
US6936256B2 (en) * | 2001-08-10 | 2005-08-30 | University Of Maryland Biotechnology Institute | Sub-unit vaccine for infectious pancreatic necrosis virus |
US7754223B2 (en) | 2003-10-07 | 2010-07-13 | Eurogentec Sa | Piscirickettsia salmonis antigens and use thereof |
DK179025B1 (da) | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
JP2010514412A (ja) | 2006-12-22 | 2010-05-06 | ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ | Dna魚ワクチン |
CA2708167C (en) | 2007-12-19 | 2016-11-29 | David Francis Kirke | Vaccine antigens from piscirickettsia salmonis |
NO346489B1 (no) * | 2008-02-08 | 2022-09-05 | Pharmaq As | Anvendelse av inaktivert SAV i fremstilling av en vaksine. |
NO333242B1 (no) * | 2008-02-08 | 2013-04-15 | Pharmaq As | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
WO2012089749A1 (en) * | 2010-12-29 | 2012-07-05 | Intervet International B.V. | Salmonid alphavirus protein e2 |
EP2688587B2 (en) | 2011-03-25 | 2023-08-16 | Intervet International B.V. | Salmonid alphavirus vaccine |
EP3037823A1 (en) | 2014-12-22 | 2016-06-29 | BioMar Group A/S | Method for determining pathological tissue damage and diagnosing infectious disease in fish |
KR102163242B1 (ko) * | 2018-06-05 | 2020-10-08 | 전남대학교산학협력단 | 무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도 |
NO344938B1 (en) | 2018-12-13 | 2020-07-20 | Patogen As | Pancreas Disease Virus Markers |
CN113122510A (zh) * | 2021-04-12 | 2021-07-16 | 中国水产科学研究院黑龙江水产研究所 | 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5165925A (en) * | 1989-05-02 | 1992-11-24 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Vaccine for immunizing fish against infectious pancreatic necrosis virus |
-
1995
- 1995-10-13 DE DE69531891T patent/DE69531891D1/de not_active Expired - Lifetime
- 1995-10-13 DK DK95202771T patent/DK0712926T3/da active
- 1995-10-13 AT AT95202771T patent/ATE251667T1/de active
- 1995-10-13 EP EP95202771A patent/EP0712926B1/en not_active Expired - Lifetime
- 1995-10-13 PT PT95202771T patent/PT712926E/pt unknown
- 1995-10-17 NO NO19954135A patent/NO317547B1/no not_active IP Right Cessation
- 1995-10-17 CA CA002160764A patent/CA2160764C/en not_active Expired - Lifetime
- 1995-10-18 JP JP27017295A patent/JP3676449B2/ja not_active Expired - Lifetime
- 1995-10-18 US US08/544,681 patent/US5939073A/en not_active Expired - Lifetime
-
1997
- 1997-05-08 US US08/854,057 patent/US5914260A/en not_active Expired - Lifetime
-
2011
- 2011-10-28 NO NO2011024C patent/NO2011024I2/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2160764C (en) | 2002-09-03 |
EP0712926B1 (en) | 2003-10-08 |
NO954135D0 (no) | 1995-10-17 |
DE69531891D1 (de) | 2003-11-13 |
PT712926E (pt) | 2004-02-27 |
CA2160764A1 (en) | 1996-04-19 |
EP0712926A3 (no) | 1996-07-03 |
JPH08228770A (ja) | 1996-09-10 |
ATE251667T1 (de) | 2003-10-15 |
JP3676449B2 (ja) | 2005-07-27 |
US5914260A (en) | 1999-06-22 |
DK0712926T3 (da) | 2004-02-09 |
US5939073A (en) | 1999-08-17 |
EP0712926A2 (en) | 1996-05-22 |
NO317547B1 (no) | 2004-11-15 |
NO2011024I2 (no) | 2015-09-07 |
NO2011024I1 (no) | 2011-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954135D0 (no) | Fiskebukspyttkjertel-sykdomsvirus | |
DK0784483T3 (da) | Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul | |
DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
DE69536039D1 (de) | Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert | |
EA200401405A1 (ru) | Модифицированный осповакцинный вирус анкара для вакцинации новорожденных | |
ATE411043T1 (de) | Verfahren von dna-impfung | |
DK1165791T3 (da) | Humant cytokin som zalpha-receptor-ligand og anvendelse deraf | |
DE69632536D1 (de) | Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren | |
DE3888086T2 (de) | Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine. | |
AU4691589A (en) | Feline infectious peritonitis virus diagnostic tools | |
ZA923321B (en) | Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus | |
ES2107033T3 (es) | Peptidos bpc, su preparacion y su utilizacion. | |
ATE237691T1 (de) | Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung | |
DK0775746T3 (da) | Vaccine mod fjerkræcoccidiose | |
WO1999058639A3 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
HU9200583D0 (en) | Method for producing el peptides of rubeola | |
PL307170A1 (en) | Vaccine against multicellular parasites | |
BR9801992A (pt) | Processos para a preparação de vìrus da doença de marek usando linhas celulares contìnuas de mamìfero. | |
FI885025A0 (fi) | Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. | |
EP0839913A3 (en) | DNA-Based vaccination of fish by immersion | |
ATE499383T1 (de) | Eine methode zur herstellung von menschlichem natürlichem interferon-alpha | |
NO942075L (no) | Rekombinante virus omfattende kunstig proteolytisk spaltingssete | |
IS3511A7 (is) | Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CB | Opposition filed (par. 26,5 patents act) |
Effective date: 20050812 |
|
PDP | Decision of opposition (par. 25 patent act) |
Free format text: PATENTSTYRETS 1. AVDELINGS AVGJORELSE AV 20060824, HVORVED TIDLIGERE MEDDELT PATENT BLE BESLUTTET OPPRETTHOLDT MOT INNSIGELSE, ER DEN 20080929 STADFESTET AV 2. AVDELING. AVGJORELSEN ER RETTSKRAFTIG. |
|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: NORVAX COMPACT PD VET.; NAT. REG. NO/DATE: MT NR 10-7431 20110818; FIRST REG. NO/DATE: VM 01708/4551 20110810 Spc suppl protection certif: 2011024 Filing date: 20111028 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: NORVAX COMPACT PD VET. INJEKSJONVAESKE, EMULSJON INTERVET; NAT. REGISTRATION NO/DATE: MT NR 10-7431 20110818; FIRST REGISTRATION: GB VM 01708/4551 20050606 Spc suppl protection certif: 2011024 Filing date: 20111028 Extension date: 20200606 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: NORVAX COMPACT PD VET. INJEKSJONSVÆSKE, EMULSJON "INTERVET"; REG.NO/DATE: MT NR 10-7431 2011.08.18; FIRST REG.NO/DATE: VM 01708/4551 2005.06.06 Spc suppl protection certif: 2011024 Filing date: 20111028 Extension date: 20200606 |
|
MK1K | Patent expired |